In this week's episode of #AskDrDurie, the IMF's Chairman Dr. Brian Durie answers a patient's question regarding how bone disease in myeloma is treated. He discusses bisphosphonates such as Aredia and Zometa and what the current recommendations are.

Dr. Brian G.M. Durie is the Chairman of the Board of Directors of the International Myeloma Foundation. He began studying multiple myeloma over 30 years ago, and is recognized around the world as one of the top myeloma doctors.

Previous Post
#AskDrDurie: Is autologous stem cell transplant still recommended?
Next Post
#AskDrDurie: If Pomalyst does not produce a full response, what are my options?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.